Trial intelligence / Profile preview

Dexmedetomidine with Rescue Propofol for Pediatric MRI Sedation

NCT04237792Phase 4Completed

Sponsor
Pfizer
Start
Feb 2020
Primary completion
Nov 2021
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of dexmedetomidine in Procedural sedation (PS), sponsored by Pfizer. Started Feb 2020; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT04237792.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04237792.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call